Literature DB >> 10993661

Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue.

L Lilge1, M Portnoy, B C Wilson.   

Abstract

The apoptotic response of normal brain and intracranial VX2 tumour following photodynamic therapy (PDT) mediated by 5 different photosensitizers (Photofrin, 5-aminolaevulinic acid (ALA)-induced protoporphyrin IX (PpIX), chloroaluminium phthalocyanine (AlCIPc), Tin Ethyl Etiopurpurin (SnET(2)), and meta -tetra(hydroxyphenyl)chlorin (m THPC)) was evaluated following a previous analysis which investigated the necrotic tissue response to PDT at 24 h post treatment. Free DNA ends, produced by internucleosomal DNA cleavage in apoptotic cells, were stained using a TUNEL (terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labelling) assay. Confocal laser scanning microscopy (CLSM) was used to quantify the local incidence of apoptosis and determine its spatial distribution throughout the brain. The incidence of apoptosis was confirmed by histopathology, which demonstrated cell shrinkage, pyknosis and karyorrhexis. At 24 h post PDT, AlClPc did not cause any detectable apoptosis, while the other photosensitizers produced varying numbers of apoptotic cells near the region of coagulative necrosis. The apoptotic response did not appear to be related to photosensitizer dose. These results suggest that at this time point, a minimal and fairly localized apoptotic effect is produced in brain tissues, the extent of which depends largely on the particular photosensitizer. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993661      PMCID: PMC2363569          DOI: 10.1054/bjoc.2000.1426

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

Review 1.  Photodynamic therapy of brain tumours--post-operative "field fractionation".

Authors:  P Muller; B Wilson
Journal:  J Photochem Photobiol B       Date:  1991-04       Impact factor: 6.252

2.  Primary lymphoma of brain: results of management of a modern cohort with radiation therapy.

Authors:  N J Laperriere; L Cerezo; M F Milosevic; C S Wong; B Patterson; T Panzarella
Journal:  Radiother Oncol       Date:  1997-06       Impact factor: 6.280

3.  Hunt for singlet oxygen under in vivo conditions.

Authors:  D Gál
Journal:  Biochem Biophys Res Commun       Date:  1994-07-15       Impact factor: 3.575

Review 4.  Therapeutic irradiation and brain injury.

Authors:  G E Sheline; W M Wara; V Smith
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-09       Impact factor: 7.038

5.  Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts.

Authors:  Q Peng; J Moan; J M Nesland; C Rimington
Journal:  Int J Cancer       Date:  1990-10-15       Impact factor: 7.396

Review 6.  Photodynamic therapy of brain tumors.

Authors:  E A Popovic; A H Kaye; J S Hill
Journal:  J Clin Laser Med Surg       Date:  1996-10

7.  Photodynamic therapy for malignant newly diagnosed supratentorial gliomas.

Authors:  P J Muller; B C Wilson
Journal:  J Clin Laser Med Surg       Date:  1996-10

8.  Association of ceramide accumulation with photodynamic treatment-induced cell death.

Authors:  D Separovic; K J Mann; N L Oleinick
Journal:  Photochem Photobiol       Date:  1998-07       Impact factor: 3.421

9.  Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.

Authors:  L Lilge; B C Wilson
Journal:  J Clin Laser Med Surg       Date:  1998-04

10.  Depth measurements and histopathological characterization of photodynamic therapy generated normal brain necrosis as a function of incident optical energy dose.

Authors:  M O Dereski; M Chopp; J H Garcia; F W Hetzel
Journal:  Photochem Photobiol       Date:  1991-07       Impact factor: 3.421

View more
  17 in total

1.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.

Authors:  Steen J Madsen; Chung-Ho Sun; Bruce J Tromberg; Henry Hirschberg
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 3.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

4.  Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.

Authors:  Ken Kang-Hsin Wang; Jarod C Finlay; Theresa M Busch; Stephen M Hahn; Timothy C Zhu
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

5.  Optical glucose analogs of aminolevulinic acid for fluorescence-guided tumor resection and photodynamic therapy.

Authors:  Eduardo H Moriyama; Weiguo Cao; Tracy W Liu; Han Lin Wang; Peter D Kim; Juan Chen; Gang Zheng; Brian C Wilson
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488

Review 6.  Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.

Authors:  Janine D Miller; Elma D Baron; Heather Scull; Andrew Hsia; Jeffrey C Berlin; Thomas McCormick; Valdir Colussi; Malcolm E Kenney; Kevin D Cooper; Nancy L Oleinick
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-15       Impact factor: 4.219

7.  Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma.

Authors:  Feng Jiang; Xuepeng Zhang; Steven N Kalkanis; Zhenggang Zhang; Hongyan Yang; Mark Katakowski; Xin Hong; Xuguang Zheng; Zhenping Zhu; Michael Chopp
Journal:  Photochem Photobiol       Date:  2008 Jan-Feb       Impact factor: 3.421

8.  The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids.

Authors:  Marlon S Mathews; Even Angell-Petersen; Rogelio Sanchez; Chung-Ho Sun; Van Vo; Henry Hirschberg; Steen J Madsen
Journal:  Lasers Surg Med       Date:  2009-10       Impact factor: 4.025

9.  Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.

Authors:  Steen J Madsen; Marlon S Mathews; Even Angell-Petersen; Chung-Ho Sun; Van Vo; Rogelio Sanchez; Henry Hirschberg
Journal:  J Neurooncol       Date:  2008-09-06       Impact factor: 4.130

10.  Post-acute response of 9L gliosarcoma to Photofrin-mediated PDT in athymic nude mice.

Authors:  Xuepeng Zhang; Feng Jiang; Steven N Kalkanis; ZhengGang Zhang; Xin Hong; Hongyan Yang; Michael Chopp
Journal:  Lasers Med Sci       Date:  2007-02-15       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.